BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9646783)

  • 21. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK.
    Nicolaides AN; Arcelus J; Belcaro G; Bergqvist D; Borris LC; Buller HR; Caprini JA; Christopoulos D; Clarke-Pearson D; Clement D
    Int Angiol; 1992; 11(3):151-9. PubMed ID: 1460347
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).
    Int Angiol; 1997 Mar; 16(1):3-38. PubMed ID: 9165356
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    Bergqvist D
    Aust N Z J Surg; 1998 Jul; 68(7):463-8. PubMed ID: 9669358
    [No Abstract]   [Full Text] [Related]  

  • 26. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prophylaxis of pulmonary embolism in pregnancy and puerperium].
    Kostrubiec M; Niewegłowska N; Pruszczyk P
    Ginekol Pol; 2010 Jan; 81(1):46-9. PubMed ID: 20232699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 30. Current recommendations for extended out-of-hospital thromboprophylaxis following total hip arthroplasty.
    Krotenberg R
    Am J Orthop (Belle Mead NJ); 2004 Apr; 33(4):180-4. PubMed ID: 15132325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of venous thromboembolism risk in hospitalized medical patients. Concordance between PRETEMED guide and the recommendations of the viii conference of the American College of Chest Physicians].
    Gallardo Jiménez P; Guijarro Merino R; Vallejo Herrera V; Sánchez Morales D; Villalobos Sánchez A; Perelló González-Moreno JI; Gómez-Huelgas R
    Med Clin (Barc); 2012 Nov; 139(11):467-72. PubMed ID: 22032816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of postoperative deep vein thrombosis of the lower limbs].
    Baeshko AA; Sysov AV; Rolevich AI
    Klin Khir; 1998; (2):38-41. PubMed ID: 9615084
    [No Abstract]   [Full Text] [Related]  

  • 33. [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].
    Zawilska K; Jaeschke R; Tomkowski W; Mayzner-Zawadzka E; Nizankowski R; Olejek A; Pasierski T; Torbicki A; Undas A; Jawień A; Gajewski P; Sznajd J; Brozek J;
    Pol Arch Med Wewn; 2009; 119 Suppl 1():1-69. PubMed ID: 19841614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk and prevention of thromboembolism complications in gynecologic malignancies].
    Graf AH; Graf B; Traun H; Staudach A
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):37-9. PubMed ID: 8737522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low-molecular-weight heparins in thromboembolic disease].
    de los Santos Sastre S; Vázquez-Oliva R; González Castro A; Barragán-Márquez F
    Med Clin (Barc); 1995 Apr; 104(16):637-8. PubMed ID: 7752718
    [No Abstract]   [Full Text] [Related]  

  • 36. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylaxis against venous thromboembolism after major trauma.
    Osler T; Rogers F
    N Engl J Med; 1997 Feb; 336(8):586; author reply 586-7. PubMed ID: 9036312
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G; Bernardi E
    Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.